Our model was built with disulfidptosis‐related risk scores which showed both accurate prediction of the prognosis of glioma patients and excellent distinction for several glioma molecular subtypes including grade, IDH mutation, MGMT promoter methylation, and 1p19q codeletion status. This evidence concerns the gene MGMT and glioma.